The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855.
KLA Corporation
KLAC · a US exchange · USD · Market cap $197.2B · 15,000 employees
KLA Corporation, together with its subsidiaries, designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide.
FAIL · Does not pass the screenPrice as of 17 Nov 2026Daily close, not a live quote
Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price144.56 USD at the 17 Nov 2026 close
- Our value readFair vs our fair value, as of 17 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans slightly to calls (put/call 0.75)
- Last reviewed17 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $139.99 to $160.99, base estimate $139.99 (screen dated 2026-11-17).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning political buying, disclosed 2026-10-13
- Options put/call open interest 0.75, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
KLA Corporation holds its Distribution at $144.56. Consolidating, no directional conviction, held for 6 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 6 days |
| Price at the screen | $144.56 |
| Valuation | 37.94 trailing · 21.32 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.50 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 37.89% | Below 33% | Interest-bearing debt is 37.9% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 15.03% | Below 33% | Cash held in interest-bearing accounts and securities is 15.0% of assets, under the one-third limit. | Pass |
| Receivables | 27.03% | Below 49% | Money owed to the company is 27.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.48% | Below 5% | Only 1.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
KLA's business is in a permissible area, but its interest-bearing debt is about 38% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when KLAC's ethical verdict changes
Today KLAC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 17 Nov 2026: it trades above our $139.99 fair value estimate, strong competitive moat, 28.90% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. The price runs 3.3% above the base estimate.
Third-party analyst targets: 26 covering, consensus Buy. The average target sits +52% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $139.99, with a range of $139.99 to $160.99, dated to the 2026-11-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it is worth knowing
A quality business: a strong moat and 36% profit margins. At the screened price it sits 3% above our $139.99 fair value: priced for the quality, not a bargain.
| Forward P/E | 21.3xcheap for a company growing this fast |
| Trailing P/E | 37.9xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 3.99 |
| EPS, forward | 7.10 |
| Revenue growth | +28.9%strong top-line growth |
| Profit margin | 36.3%highly profitable on every dollar of sales |
| Return on equity | 91.4%an exceptional return on shareholder capital |
| FCF yield | 1.43% |
| Dividend yield | 0.49% |
| Debt to equity | 0.92moderate, manageable leverage |
| Current ratio | 2.76comfortably covers its short-term bills |
| Beta | 1.50moves a little more than the market |
| Short interest, float | 0.02% |
| 52-week range | 107.20 - 307.37 |
| Moat | STRONG |
| Market cap | $197.2B |
| Employees | 15,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeKLAC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. Since the last review it its composite score rose.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- KLA Corporation (KLAC) Shares Pull Back Amid Semiconductor Sell-Off Yahoo Finance · 15h ago
- KLAC is Overvalued at 9.37X P/S: Buy, Sell or Hold the Stock? Yahoo Finance · 15h ago
- Brad Gerstner Dumps These 3 Stocks Yahoo Finance · 16h ago
- Lam Research Stock Fell Nearly 7%. What Happened? Yahoo Finance · 17h ago
- Is It Worth Investing in KLA (KLAC) Based on Wall Street's Bullish Views? Yahoo Finance · 18h ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | WALLACE RICHARD P | Chief Executive Officer | 4,512 | $8,094,528 | |
| 2026-05-11 | HANLEY JENEANNE MICHELLE | Director | 550 | $1,031,088 | |
| 2026-05-11 | KIRLOSKAR VIRENDRA A | Officer | 297 | $558,069 | |
| 2026-02-05 | CALDERONI ROBERT M | Director | 11 | · | |
| 2025-12-16 | HIGGINS BREN D. | Chief Financial Officer | 2,254 | $2,788,221 | |
| 2025-11-12 | KHAN AHMAD A | Officer | 85 | · | |
| 2025-11-11 | WALLACE RICHARD P | Chief Executive Officer | 804 | · | |
| 2025-11-11 | WALLACE RICHARD P | Chief Executive Officer | 10,803 | $12,997,089 | |
| 2025-11-05 | CALDERONI ROBERT M | Director | 256 | · | |
| 2025-11-05 | SAMATH JAMIE E. | Director | 203 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-13 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-07-01 | Michael Rulli | Republican | buy | 1K–15K |
| 2024-05-03 | Tommy Tuberville | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,842.84 | +16.4% | $2.30 | $1,166 | +16.6% |
| 2 months | $1,735.07 | +23.7% | $2.30 | $1,238 | +23.8% |
| 3 months | $1,407.77 | +52.4% | $2.30 | $1,526 | +52.6% |
| 6 months | $1,242.98 | +72.6% | $4.20 | $1,730 | +73.0% |
| 1 year | $851.10 | +152.1% | $8.00 | $2,531 | +153.1% |
| 2 years | $782.02 | +174.4% | $14.75 | $2,763 | +176.3% |
| 3 years | $453.97 | +372.7% | $20.40 | $4,772 | +377.2% |
| 5 years | $304.29 | +605.2% | $29.80 | $7,150 | +615.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever KLAC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.